Patient Portal

Mario Castro, MD, MPH, FCCP

Professor, Medicine and Pediatrics
Division of Pulmonary and Critical Care Medicine

Specialty Areas

Pulmonary Disease
Asthma
Lung Cancer

Board Certifications

Pulmonary Disease
Internal Medicine
Critical Care Medicine

Hospital Affiliations

Barnes-Jewish Hospital
Barnes-Jewish West County Hospital

Areas of Clinical Interest

Asthma and related allergic disease, COPD, emphysema, chronic bronchitis, interstital lung disease, idiopathic pulmonary fibrosis, sarcoidosis, chronic cough, unexplained shortness of breath, vasculitis, chronic lung infections, pulmonary hypertension, bronchiectasis.

  • Location(s)
  • Education
  • Publication & Research
  • Financial Disclosures

Location(s)

Location(s)

Center for Advanced Medicine
Lung Center

4921 Parkview Place
St. Louis, MO 63110

Suite: B
Floor: 8
Office Phone: 314-454-8917

Education

Education

Graduate: Public Health, St. Louis University School of Public Health, St. Louis, Missouri 1998
Fellowship: Pulmonary/Critical Care, Mayo Clinic, Mayo Graduate School of Medicine, Rochester, Minnesota 1994
Residency: Internal Medicine, Mayo Clinic, Mayo Graduate School of Medicine, Rochester, Minnesota 1991
Medical Degree: University Of Missouri, Kansas City, Missouri 1988

Publication & Research

Publication & Research

Facial tumor as a presenting complaint in a patient with primary Sjögren's syndrome.
González-Mourelle A, Castro MP, Mahía IV, López JC, Neagu D, López-Cedrún JL
Natl J Maxillofac Surg. 2019 Jan-Jun; 10(1)87-90. doi: 10.4103/njms.NJMS_3_18.

PMID:
    31205394
    [PubMed]
Related citations


New Serotoninergic Ligands Containing Indolic and Methyl Indolic Nuclei: Synthesis and in Vitro Pharmacological Evaluation.
Magli E, Severino B, Corvino A, Perissutti E, Frecentese F, Saccone I, Giordano F, Castro M, Brea J, Loza MI, Santagada V, Caliendo G, Fiorino F
Med Chem. 2019 Jun 13; doi: 10.2174/1573406415666190613153220.

PMID:
    31203804
    [PubMed - as supplied by publisher]
Related citations


Outcomes following mepolizumab treatment discontinuation: real-world experience from an open-label trial.
Ortega H, Lemiere C, Llanos JP, Forshag M, Price R, Albers F, Yancey S, Castro M
Allergy Asthma Clin Immunol. 2019; 1537. doi: 10.1186/s13223-019-0348-z.

PMID:
    31198427
    [PubMed]
Related citations


Major risk factors for leprosy in a non-endemic area of the United States: A case series.
Aslam S, Peraza J, Mekaiel A, Castro M, Casanas B
IDCases. 2019; 17e00557. doi: 10.1016/j.idcr.2019.e00557.

PMID:
    31193361
    [PubMed]
Related citations


Regional variation in the incidence rate and sex ratio of multiple sclerosis in Scotland 2010-2017: findings from the Scottish Multiple Sclerosis Register.
Kearns PKA, Paton M, O'Neill M, Waters C, Colville S, McDonald J, Young IJB, Pugh D, O'Riordan J, Weller B, MacDougall N, Clemens T, Dibben C, Wilson JF, Castro MC, Ascherio A, Chandran S, Connick P
J Neurol. 2019 Jun 11; doi: 10.1007/s00415-019-09413-x.

PMID:
    31187189
    [PubMed - as supplied by publisher]
Related citations


Distinct YFV Lineages Co-circulated in the Central-Western and Southeastern Brazilian Regions From 2015 to 2018.
Delatorre E, de Abreu FVS, Ribeiro IP, Gómez MM, Dos Santos AAC, Ferreira-de-Brito A, Neves MSAS, Bonelly I, de Miranda RM, Furtado ND, Raphael LMS, da Silva LFF, de Castro MG, Ramos DG, Romano APM, Kallás EG, Vicente ACP, Bello G, Lourenço-de-Oliveira R, Bonaldo MC
Front Microbiol. 2019; 101079. doi: 10.3389/fmicb.2019.01079.

PMID:
    31178835
    [PubMed]
Related citations


A software for testing and training visuo-motor coordination for upper limb control.
Oliveira AS, Andersen CØ, Grimstrup CB, Pretzmann F, Mortensen NH, Castro MN, Mrachacz-Kersting N
J Neurosci Methods. 2019 Jun 6; 324108310. doi: 10.1016/j.jneumeth.2019.06.002.

PMID:
    31175892
    [PubMed - as supplied by publisher]
Related citations


Environmental impact of combustion of ethanolic biodiesel/diesel blends from several feedstocks on the gas emission levels in the atmosphere.
Pinheiro TF, Castro MPP, Perez VH, Silveira Junior EG, Sthel MS, da Silva MG
Environ Sci Pollut Res Int. 2019 Jun 8; doi: 10.1007/s11356-019-05212-z.

PMID:
    31175574
    [PubMed - as supplied by publisher]
Related citations


Proteome Dataset of Qualea grandiflora Mart. (Vochysiaceae) by LC-MS/MS Label-Free Identification in Response to Aluminium.
Cury NF, Silva RCC, Fayad M, Fontes W, Ricart CAO, Castro MS, Silveira CES, de Sousa V, Pereira LAR
Proteomics. 2019 Jun 6; e1900148. doi: 10.1002/pmic.201900148.

PMID:
    31168931
    [PubMed - as supplied by publisher]
Related citations


Imaging Methodology for Hip Preservation: Techniques, Parameters, and Thresholds.
Mascarenhas VV, Ayeni OR, Egund N, Jurik AG, Caetano A, Castro M, Novo J, Gonçalves S, Sutter R
Semin Musculoskelet Radiol. 2019 Jun; 23(3)197-226. doi: 10.1055/s-0039-1688714.

PMID:
    31163499
    [PubMed - in process]
Related citations


Social and Structural Determinants of Urban American Indian and Alaska Native Health: A Case Study in Los Angeles.
Garcia AN, Castro MC, Sánchez JP
MedEdPORTAL. 2019 May 15; 1510825. doi: 10.15766/mep_2374-8265.10825.

PMID:
    31161137
    [PubMed - in process]
Related citations


Circuit-specific control of the medial entorhinal inputs to the dentate gyrus by atypical presynaptic NMDARs activated by astrocytes.
Savtchouk I, Di Castro MA, Ali R, Stubbe H, Luján R, Volterra A
Proc Natl Acad Sci U S A. 2019 May 31; pii: 201816013. doi: 10.1073/pnas.1816013116.

PMID:
    31152131
    [PubMed - as supplied by publisher]
Related citations


IL7 receptor signaling in T cells: A mathematical modeling perspective.
Park JH, Waickman AT, Reynolds J, Castro M, Molina-París C
Wiley Interdiscip Rev Syst Biol Med. 2019 May 28; e1447. doi: 10.1002/wsbm.1447.

PMID:
    31137085
    [PubMed - as supplied by publisher]
Related citations


Is possible to rule out clinically significant prostate cancer using PI-RADS v2 for the assessment of prostate MRI?
Viana PCC, Horvat N, do Santos VR Júnior, Lima TC, Romão DDS, Cerri LMO, de Castro MG, Vargas HA, Miranda JA, Leite CDC, Cerri GG
Int Braz J Urol. 2019 May 15; 45doi: 10.1590/S1677-5538.IBJU.2018.0382.

PMID:
    31136114
    [PubMed - as supplied by publisher]
Related citations


Assessing the construct validity of clinical tests to identify sacroiliac joint inflammation in patients with non-radiographic axial spondyloarthritis.
Castro MP, Stebbings SM, Milosavljevic S, Pedersen SJ, Bussey MD
Int J Rheum Dis. 2019 May 27; doi: 10.1111/1756-185X.13606.

PMID:
    31131990
    [PubMed - as supplied by publisher]
Related citations


Determinants of long-term outcome of repaired pulmonary valve stenosis.
Galian-Gay L, Gordon B, Marsal JR, Rafecas A, Pijuan Domènech A, Castro MA, Subirana Domènech MT, Sureda C, Miranda B, Martí G, García-Dorado D, Dos Subirà L
Rev Esp Cardiol (Engl Ed). 2019 May 24; pii: S1885-5857(19)30075-1. doi: 10.1016/j.rec.2019.02.014.

PMID:
    31130344
    [PubMed - as supplied by publisher]
Related citations


Exploiting the Synergistic Effect of Kairomones and Light-Emitting Diodes on the Attraction of Phlebotomine Sand Flies to Light Traps in Brazil.
da Silva AA, Rebêlo JMM, Carneiro BF, Castro MPP, de Sousa de Almeida M, Ponte IS, Aguiar JVC, Silva FS
J Med Entomol. 2019 May 23; pii: tjz073. doi: 10.1093/jme/tjz073.

PMID:
    31121023
    [PubMed - as supplied by publisher]
Related citations


Papillary muscle rupture: Correlation between echocardiography and surgical pathology.
Castro M, Abecasis J, Gouveia R, Ribeiras R, Abecasis M
Rev Port Cardiol. 2019 Apr; 38(4)305-306. doi: 10.1016/j.repc.2018.09.010.

PMID:
    31113694
    [PubMed - in process]
Related citations


Validation of subject-specific musculoskeletal models using the anatomical reachable 3-D workspace.
Castro MN, Rasmussen J, Bai S, Andersen MS
J Biomech. 2019 Jun 11; 9092-102. doi: 10.1016/j.jbiomech.2019.04.037.

PMID:
    31113575
    [PubMed - in process]
Related citations


Mometasone or Tiotropium in Mild Asthma with a Low Sputum Eosinophil Level.
Lazarus SC, Krishnan JA, King TS, Lang JE, Blake KV, Covar R, Lugogo N, Wenzel S, Chinchilli VM, Mauger DT, Dyer AM, Boushey HA, Fahy JV, Woodruff PG, Bacharier LB, Cabana MD, Cardet JC, Castro M, Chmiel J, Denlinger L, DiMango E, Fitzpatrick AM, Gentile D, Hastie A, Holguin F, Israel E, Jackson D, Kraft M, LaForce C, Lemanske RF Jr, Martinez FD, Moore W, Morgan WJ, Moy JN, Myers R, Peters SP, Phipatanakul W, Pongracic JA, Que L, Ross K, Smith L, Szefler SJ, Wechsler ME, Sorkness CA, National Heart, Lung, and Blood Institute AsthmaNet.
N Engl J Med. 2019 May 23; 380(21)2009-2019. doi: 10.1056/NEJMoa1814917.

PMID:
    31112384
    [PubMed - indexed for MEDLINE]
Related citations

Financial Disclosures

Financial Disclosures

Disclosure of Financial Interests with Industry

Washington University and its physicians and health professionals are committed to ensuring integrity and objectivity in medical decision-making. Some of our physicians and health professionals work collaboratively with pharmaceutical, medical device or other medical care related companies to develop innovative ideas and products that can improve health care delivery and clinical outcomes for patients. In some instances, our physicians and health professionals have an ownership or potential ownership interest in a commercial company; and/or are paid by a commercial company to provide advice on product design or to speak about the use of medications, devices, equipment or procedures. These payments may include: a) compensation for consulting and speaking engagements, b) equity, and/or c) royalties for products invented by our faculty. Any payments to Washington University physicians or health professionals must be based on tangible services and may not exceed fair market value for their work. In addition to disclosure on this website, physicians and health professionals earning more than $10,000 per year must disclose their corporate financial relationship in writing to patients when prescribing or using that company's products.

This physician reported the following financial interests during calendar year 2018:

Company Name: Astrazenica

Royalties:

Equity: No

Consulting/Advisory Board:

Speaker Fees: $150,000 - $199,999

Reporting Date: May 01, 2019


Company Name: Genetech

Royalties:

Equity: No

Consulting/Advisory Board:

Speaker Fees: $20,000 - $39,999

Reporting Date: May 01, 2019


Company Name: Teva

Royalties:

Equity: No

Consulting/Advisory Board:

Speaker Fees: $100,000 - $149,999

Reporting Date: May 01, 2019